Physician

Samuel Kenney Houston, MD

According to 2025 Medicare claims, Samuel Houston, MD (NPI: 1851533236) practices ophthalmology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 32159-4540.

Houston's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,156 traditional Medicare patients, billed 42,642 HCPCS/CPT codes, and received $4,075,352 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 861 prescription claims across 297 beneficiaries totaling $590,591 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 31 records totaling $5,526. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $296,523 to $4,075,352. Similarly, Part D prescription costs have risen steadily, from $9,830 to $590,591. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.3M2015 Medicare payment: $296,523 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,063,453 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,733,311 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,027,074 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,502,882 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,712,408 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,667,499 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,186,600 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,315,358 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,075,352 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156813,361$296,523
20161,08610,840$1,063,453
20171,37114,857$1,733,311
20181,58518,020$3,027,074
20191,51516,993$3,502,882
20201,32316,090$3,712,408
20211,21216,064$3,667,499
20221,38020,656$4,186,600
20231,27941,024$4,315,358
20241,15642,642$4,075,352

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$320K$639K2015 Drug cost: $9,830 (USD; Tot_Drug_Cst)2016 Drug cost: $89,996 (USD; Tot_Drug_Cst)2017 Drug cost: $263,815 (USD; Tot_Drug_Cst)2018 Drug cost: $294,092 (USD; Tot_Drug_Cst)2019 Drug cost: $639,275 (USD; Tot_Drug_Cst)2020 Drug cost: $598,263 (USD; Tot_Drug_Cst)2021 Drug cost: $412,533 (USD; Tot_Drug_Cst)2022 Drug cost: $480,788 (USD; Tot_Drug_Cst)2023 Drug cost: $571,894 (USD; Tot_Drug_Cst)2024 Drug cost: $590,591 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201583168$9,830
2016171494$89,996
2017244676$263,815
2018269737$294,092
2019293943$639,275
2020279953$598,263
2021252782$412,533
2022310970$480,788
2023331967$571,894
2024297861$590,591

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3632,936$639
67028Injection of drug into eye5222,151$94
92014Established patient complete exam of visual system735882$88
92134Imaging of retina6051,748$30
92250Photography of the retina9921,188$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept1584,424$349,689
VabysmoFaricimab-Svoa511,428$133,541
Eylea HdAflibercept14448$47,259
LumiganBimatoprost11635$5,151
Prednisolone AcetatePrednisolone Acetate1225,449$5,147

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$5,526Alcon Research LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Samuel Kenney Houston, MD?

Tedicare shows public-source Medicare data for Samuel Kenney Houston, MD (NPI 1851533236), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Kenney Houston, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Samuel Kenney Houston, MD?

Samuel Kenney Houston, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Samuel Kenney Houston, MD have Open Payments data?

Samuel Kenney Houston, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.